Ftse Mib
37.977,59
0,18%
DAX
22.513,42
-0,43%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
97.711,87
0,20%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Protagonist Therapeutics Inc (PTGX) Protagonist Therapeutics Inc (PTGX) Notizie

Protagonist Therapeutics Inc

PTGX
38,67
-0,01 (-0,03%)
15 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/2/202519:23EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
17/1/202523:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202523:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202500:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202500:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202500:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202500:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202500:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202500:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:05EDGAR2Form 8-K - Current report
28/11/202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202422:39EDGAR2Form 144 - Report of proposed sale of securities
27/11/202401:39EDGAR2Form 144 - Report of proposed sale of securities
27/11/202401:37EDGAR2Form 144 - Report of proposed sale of securities
25/11/202423:40EDGAR2Form 144 - Report of proposed sale of securities
20/11/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:36EDGAR2Form 8-K - Current report
20/9/202422:05EDGAR2Form 8-K - Current report
13/9/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202400:15EDGAR2Form 144 - Report of proposed sale of securities
10/9/202422:17EDGAR2Form 144 - Report of proposed sale of securities
06/8/202422:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202413:08EDGAR2Form 8-K - Current report
26/7/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202422:33EDGAR2Form 144 - Report of proposed sale of securities
27/6/202423:44PRNUSProtagonist Therapeutics Set to Join S&P SmallCap 600
11/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:46EDGAR2Form 144 - Report of proposed sale of securities
07/5/202422:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:29EDGAR2Form 8-K - Current report
16/4/202415:00GLOBETurnstone Biologics Appoints William Waddill to its Board of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:27EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:32EDGAR2Form 144 - Report of proposed sale of securities
29/2/202423:48EDGAR2Form 144 - Report of proposed sale of securities
29/2/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:12EDGAR2Form 8-K - Current report
Apertura: 38,74 Min: 38,36 Max: 39,37
Chiusura: 38,68

La tua Cronologia

NASDAQ
PTGX
Protagonist Therapeutics
NASDAQ
IDWK
International Displayworks
BIT
F29688
Vontobel Financial Produ...
BIT
Z59248
Credit Suisse
BIT
F34603
Vontobel Financial Produ...
BIT
UB1X6D
UniCredit Bank
BIT
P45420
Bnp Paribas Issuance
BOV
A1LN34M
Alnylam Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci